NDC 15370-250

TriStart DHA

Ascorbic Acid, Cholecalciferol, .alpha.-tocopherol Acetate, D-, Thiamine Hydrochloride, Riboflavin, Niacin, Pyridoxine Hydrochloride, Levomefolate Magnesium, Folic Acid, Cyanocobalamin, Iron Pentacarbonyl, Potassium Iodide, Magnesium Oxide, Doconexent, And Icosapent

TriStart DHA is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by Carwin Pharmaceutical Associates, Llc. The primary component is Ascorbic Acid; Cholecalciferol; .alpha.-tocopherol Acetate, D-; Thiamine Hydrochloride; Riboflavin; Niacin; Pyridoxine Hydrochloride; Levomefolate Magnesium; Folic Acid; Cyanocobalamin; Iron Pentacarbonyl; Potassium Iodide; Magnesium Oxide; Doconexent; Icosapent.

Product ID15370-250_80999e4b-a99b-4abd-b082-0ac6febebb1d
NDC15370-250
Product TypeHuman Prescription Drug
Proprietary NameTriStart DHA
Generic NameAscorbic Acid, Cholecalciferol, .alpha.-tocopherol Acetate, D-, Thiamine Hydrochloride, Riboflavin, Niacin, Pyridoxine Hydrochloride, Levomefolate Magnesium, Folic Acid, Cyanocobalamin, Iron Pentacarbonyl, Potassium Iodide, Magnesium Oxide, Doconexent, And Icosapent
Dosage FormCapsule, Liquid Filled
Route of AdministrationORAL
Marketing Start Date2015-06-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameCarWin Pharmaceutical Associates, LLC
Substance NameASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL ACETATE, D-; THIAMINE HYDROCHLORIDE; RIBOFLAVIN; NIACIN; PYRIDOXINE HYDROCHLORIDE; LEVOMEFOLATE MAGNESIUM; FOLIC ACID; CYANOCOBALAMIN; IRON PENTACARBONYL; POTASSIUM IODIDE; MAGNESIUM OXIDE; DOCONEXENT; ICOSAPENT
Active Ingredient Strength55 mg/1; [iU]/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; mg/1
Pharm ClassesVitamin C [EPC],Ascorbic Acid [CS],Vitamin D [CS],Vitamin D [EPC],Nicotinic Acid [EPC],Nicotinic Acids [CS],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15370-250-30

30 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (15370-250-30)
Marketing Start Date2015-06-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15370-250-30 [15370025030]

TriStart DHA CAPSULE, LIQUID FILLED
Marketing CategoryUNAPPROVED DRUG OTHER
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-06-01

Drug Details

Active Ingredients

IngredientStrength
ASCORBIC ACID55 mg/1

OpenFDA Data

SPL SET ID:92ccf7d4-4527-49f0-b890-1a11b5a10086
Manufacturer
UNII
UPC Code
  • 0315370250307
  • Pharmacological Class

    • Vitamin C [EPC]
    • Ascorbic Acid [CS]
    • Vitamin D [CS]
    • Vitamin D [EPC]
    • Nicotinic Acid [EPC]
    • Nicotinic Acids [CS]
    • Vitamin B6 Analog [EPC]
    • Vitamin B 6 [Chemical/Ingredient]
    • Analogs/Derivatives [Chemical/Ingredient]
    • Vitamin B 12 [CS]
    • Vitamin B12 [EPC]
    • Calculi Dissolution Agent [EPC]
    • Magnesium Ion Exchange Activity [MoA]
    • Osmotic Laxative [EPC]
    • Osmotic Activity [MoA]
    • Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
    • Increased Large Intestinal Motility [PE]
    • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
    • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.